wool clothing
Othersuperfine merino wool ensembles for baby wear
NCT Number: NCT02534428
The study is a sequentially recruited, cross-over-cohort, outpatient-based evaluation of the effectiveness of wool clothing, as compared to standard clothing, in reducing the severity of childhood atopic dermatitis over two consecutive six-week periods.
Looking for future studies?
Notify MeUp to 3 year
All sexes
Interventional
Not applicable
The study will aim for a sample size of approximately 40 patients between the ages of 0 and 3 years of children referred to the Dermatology Department at the Royal Children's Hospital for management of mild to moderate atopic dermatitis. They will be sequentially recruited and randomized to the wool-standard clothing arm or standard clothing-wool arm.
The study will run for 12 weeks for each participant with two 6-week periods, either of wool followed by standard clothing or standard followed by wool clothing. Participants will be assessed by a blinded trained researcher during this time, at their initial appointment, 3 weeks, 6 weeks, 9 weeks and 12 weeks.
The primary outcome is change in the severity of atopic eczema at 6 weeks. Severity of atopic eczema will be measured using the Scoring Atopic Dermatitis (SCORAD) index.
Secondary outcomes include the change in the severity of eczema using the SCORAD at 3 weeks and the Atopic Dermatitis Severity Index (ADSI) score at 3 and 6 weeks and quality of life assessment using the Dermatology Life Quality Index (DLQI) at 3 and 6 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
superfine merino wool ensembles for baby wear
Time frame: at 6 weeks
blinded assessor administered SCORAD
Time frame: at 3 weeks
blinded assessor administered SCORAD
Time frame: at 6 weeks
blinded assessor administered ADSI
Time frame: at 3 weeks
blinded assessor administered ADSI
Time frame: at 6 weeks
Time frame: at 3 weeks
Time frame: at 6 weeks
Time frame: at 3 weeks
Time frame: at 6 weeks
Time frame: at 3 weeks
Murdoch Childrens Research Institute
Other
The Effects of Superfine Merino Wool in the Management of Childhood Atopic Dermatitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06324812
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Beijing, Beijing Municipality, China
View Trial DetailsNCT04365387
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Phoenix, Arizona, United States
View Trial DetailsNCT06173284
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Beijing, Beijing Municipality, China
View Trial DetailsNCT03422822
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Birmingham, Alabama, United States
View Trial Details